These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 5820115)

  • 1. Analysis of the central vasomotor effects of (-)-N-(1-phenylethyl)guanidine, a new adrenergic neuron blocking agent.
    Bapat SK; Dhawan BN; Srimal RC
    Can J Physiol Pharmacol; 1969 Aug; 47(8):725-9. PubMed ID: 5820115
    [No Abstract]   [Full Text] [Related]  

  • 2. Sympathetic nervous system blocking agents. 3. Derivatives of benzylguanidine.
    Short JH; Darby TD
    J Med Chem; 1967 Sep; 10(5):833-40. PubMed ID: 6057834
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacology of N-[2-(2,6-xylyloxy)ethyl]-guanidine sulphate; an adrenergic neurone blocking agent.
    Barron DI; Natoff IL; Vallance DK
    Br J Pharmacol Chemother; 1965 Oct; 25(2):534-44. PubMed ID: 5866731
    [No Abstract]   [Full Text] [Related]  

  • 4. Central vasomotor effects of a new ganglion-blocking agent--1: 2: 2: 6: 6-pentamethyl piperidine (pempidine).
    DHAWAN KN; BHARGAVA KP
    Br J Pharmacol Chemother; 1960 Jun; 15(2):215-8. PubMed ID: 13848257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual actions of some N-(1-phenylethyl)guanidines on the nictitating membrane of conscious cats.
    Fielden R
    J Pharm Pharmacol; 1967 Apr; 19(4):217-20. PubMed ID: 4382304
    [No Abstract]   [Full Text] [Related]  

  • 6. Facilitation of ganglionic transmission by some adrenergic neurone blocking drugs.
    Farmer JB; Rand MJ; Wilson J
    Int J Neuropharmacol; 1966 May; 5(3):241-6. PubMed ID: 4380550
    [No Abstract]   [Full Text] [Related]  

  • 7. [Analysis of action of corazole on central mechanisms of regulation of vascular tonus].
    Tsyrlin VA
    Farmakol Toksikol; 1969; 32(6):669-73. PubMed ID: 5381596
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of clonidine on the excitability of vasomotor loci in the cat.
    Dhawan BN; Johri MB; Singh GB; Srimal RC; Viswesaram D
    Br J Pharmacol; 1975 May; 54(1):17-21. PubMed ID: 1139074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of cyclopropane on the central vasomotor mechanism of the dog.
    Markee S; Wang HH; Wang SC
    Anesthesiology; 1966; 27(6):742-55. PubMed ID: 5924546
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of new guanidine derivatives on ganglionic and neuromuscular transmission.
    Kadzielawa K; Gumulka W
    Arch Int Pharmacodyn Ther; 1967 Dec; 170(2):297-309. PubMed ID: 4294771
    [No Abstract]   [Full Text] [Related]  

  • 11. Simulated alpha-blockade due to inhibition of release of nor-epinephrine by a beta-blocking agent Ko 592.
    Redisch W; Clauss RH; Terry EN; Rouen L
    J Cardiovasc Surg (Torino); 1970; 11(2):141-5. PubMed ID: 4394165
    [No Abstract]   [Full Text] [Related]  

  • 12. "Alpha" and "beta" adrenergic receptors in the medullary vasomotor center of the cat.
    Share NN
    Arch Int Pharmacodyn Ther; 1973 Apr; 202(2):362-73. PubMed ID: 4632860
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on the antagonism between the optical isomers of N-(1-phenylethyl)guanidine.
    Fielden R; Green AL
    Br J Pharmacol Chemother; 1966 Jan; 26(1):264-70. PubMed ID: 5919510
    [No Abstract]   [Full Text] [Related]  

  • 14. THE ADRENERGIC-NEURONE BLOCKING ACTION OF SOME COUMARAN COMPOUNDS.
    FIELDEN R; ROE AM; WILLEY GL
    Br J Pharmacol Chemother; 1964 Dec; 23(3):486-507. PubMed ID: 14256809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacology of the adrenergic blocking agent dimethylpiperidino ethyl guanidine (author's transl)].
    Chen WZ; Wang ZM; Ting KS
    Yao Xue Xue Bao; 1979 Aug; 14(8):480-5. PubMed ID: 532648
    [No Abstract]   [Full Text] [Related]  

  • 16. The adrenergic neurone blocking action of [2-(methylphenylamino)ethyl]guanidine sulfate. I.
    Ozawa H; Sato S
    Chem Pharm Bull (Tokyo); 1966 Nov; 14(11):1291-7. PubMed ID: 5979175
    [No Abstract]   [Full Text] [Related]  

  • 17. The adrenergic blocking activity of two phenoxathiinium compounds.
    Shriver SL; Rudzik AD
    Arch Int Pharmacodyn Ther; 1967 Sep; 169(1):211-20. PubMed ID: 6055130
    [No Abstract]   [Full Text] [Related]  

  • 18. Sympathetic nervous system blocking agents. V. Derivatives of isobutyl-, t-butyl-, and neopentylguanidine.
    Short JH; Ours CW; Ranus WJ
    J Med Chem; 1968 Nov; 11(6):1129-35. PubMed ID: 5680024
    [No Abstract]   [Full Text] [Related]  

  • 19. The site of cardiovascular action of angiotensin II in the brain.
    Joy MD; Lowe RD
    Clin Sci; 1970 Aug; 39(2):327-36. PubMed ID: 4319701
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of histamine and antihistaminics on central vasomotor loci.
    Sinha JN; Gupta ML; Bhargava KP
    Eur J Pharmacol; 1969 Feb; 5(3):235-8. PubMed ID: 4388969
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.